Annandale Capital »

Regenxbio Inc equity us cm shares owned by Annandale Capital

Quarter-by-quarter ownership of Regenxbio Inc equity us cm (RGNX) shares owned by Annandale Capital from 13F filings

Historical chart of Annandale Capital investment in Regenxbio Inc equity us cm

Tip: Access up to 7 years of quarterly data

All positions including Regenxbio Inc equity us cm held by Annandale Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regenxbio Inc equity us cm by Annandale Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $60k 3.6k 16.59

More positions owned by Annandale Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Dimensional Etf Trust Us Core Equity 1 (DCOR)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Vanguard Whitehall Fds High Div Yld (VYM)
Meta Platforms Cl A (META)
Ishares Tr Us Treas Bd Etf (GOVT)
Global X Fds Glb X Mlp Enrg I (MLPX)
Uber Technologies (UBER)
Netflix (NFLX)
Ishares Tr Russell 2000 Etf (IWM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)

View all positions for Annandale Capital

Top funds holding Regenxbio Inc equity us cm

BlackRock
Redmile Group
Jpmorgan Chase & Co
Vanguard Group
State Street Corporation
Goldman Sachs Group
AQR Capital Management
Geode Capital Management
Dimensional Fund Advisors
Integral Health Asset Management
22NW
Nuveen
Voss Capital
Invenomic Capital Management
Northern Trust

View all funds holding Regenxbio Inc equity us cm